ArticleCephalalgia : an international journal of headache2021

Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment - a real-life cohort study.

Andreas R Gantenbein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.